Seemal R. Desai

1 month ago | healio.com | Rebecca Forand |Kristen Dowd |Seemal R. Desai

Key takeaways: Current AAD President Seemal R. Desai, MD, FAAD, addressed the Skin of Color Society regarding leadership. Desai touted the importance of taking one’s individual journey toward leadership roles. ORLANDO — Seemal R. Desai, MD, FAAD, who is finishing his term as American Academy of Dermatology president, took time to reflect on his own leadership journey and inspire future leaders at the Skin of Color Society Scientific Symposium.

1 month ago | ajmc.com | Cameron Santoro |Seemal R. Desai

This content was produced independently by The American Journal of Managed Care® (AJMC®) and is not endorsed by the American Academy of Dermatology. Seemal R. Desai, MD, FAAD, president of the American Academy of Dermatology (AAD), stated he is most looking forward to enhancing the member experience at the 2025 annual meeting. He aims to revamp the meeting's flow and introduce new events.

Jan 21, 2025 | healio.com | Gabrielle Capaldo |Seemal R. Desai |Kristen Dowd

You've successfully added Practice Management in Dermatology to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: The Wall Street Journal has claimed dermatology is a glamorous, laid-back and lucrative specialty. Seemal R. Desai, MD, FAAD, president of the AAD, tackled these claims.

Dec 9, 2024 | managedhealthcareexecutive.com | Seemal R. Desai

December 9, 2024By The panelist discusses how vitiligo’s psychological and social impacts significantly affect patients’ quality of life and treatment adherence, necessitating a holistic approach that addresses both physical symptoms and psychosocial support needs. Video content above is prompted by the following: How do the psychological and social impacts of vitiligo affect your patients? How do you address these issues?

Dec 2, 2024 | managedhealthcareexecutive.com | Seemal R. Desai

December 2, 2024By Seemal Desai, M.D., FAAD, discusses how managed care organizations can improve access to advanced vitiligo treatments through updated formulary decisions and treatment algorithms while addressing insurance coverage barriers and balancing treatment aggressiveness with value-based care considerations. Video content above is prompted by the following: How might they affect managed care formularies and treatment algorithms?